Company: TLSA
Filing Date: 2025-03-24
Form Type: F-3
Source: 0001013762-25-001691
Chunk: 54

Company: Tiziana Life Sciences Ltd
Filing Date: 2025-03-24
Form: F-3
Chunk 54
---
 transaction
date. In addition, we could be subject to enforcement actions or penalties and fines by federal and/or state regulatory authorities. We
cannot predict the likelihood of any claims or actions being brought against us or the amount of any penalties or fines in connection
with the Sales.

Our common shares may be delisted from The Nasdaq Capital Market if we fail to comply with continued listing standards.

If we fail to meet any of the continued listing standards of The Nasdaq Capital Market, our common shares could be delisted from The Nasdaq Capital Market. These continued listing standards include specifically enumerated criteria, such as:

| ● | a $1.00 minimum closing 
 bid price;              |

| ● | stockholders’ equity 
 of $2.5 million;     |

| ● | 500,000 shares of publicly-held                          
 common stock with a market value of at least $1 million; |

| ● | 300 round-lot stockholders; 
 and                         |

| ● | compliance with Nasdaq’s                                                                                                            
 corporate governance requirements, as well as additional or more stringent criteria that may be applied in the exercise of Nasdaq’s 
 discretionary authority.                                                                                                            |

On January 29, 2025, we received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) that we were not currently in compliance with the $1.00 Minimum Bid Price Requirement for continued listing of our common shares on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Notice indicated that, consistent with Nasdaq Listing Rule 5810(c)(3)(A), we had until July 28, 2025, to regain compliance with the Minimum Bid Price Requirement by having the closing bid price of our common shares meet or exceed $1.00 per common share for at least ten consecutive business days.

On March 14, 2025, we announced that Nasdaq informed us that we regained compliance with the Minimum Bid Price Requirement for continued listing on The Nasdaq Capital Market.

If we fail to comply with Nasdaq’s continued listing standards, we may be delisted and our common shares will trade, if at all, only on the over-the-counter market, such as the OTC Bulletin Board or OTCQX market, and then only if one or more registered broker-dealer market makers comply with quotation requirements. In addition, delisting of our common shares could depress our stock price, substantially limit liquidity